Sean Duffy
Co-Founder and CEO, Omada Health. On 1 show, 4 appearances. The Shows tab opens the full record on each.
founderexecutive@seanduffy ↗LinkedIn ↗omadahealth.com ↗
Sean Duffy co-founded Omada Health in 2011, pioneering virtual-first chronic care management for prediabetes, type 2 diabetes, hypertension, and musculoskeletal conditions. A former Harvard MD/MBA candidate and Columbia neuroscience graduate, he previously worked at Google and IDEO.
1shows
4appearances
46statements
15resolved
12supported
1contradicted
80%fully supported
1said about them ↓ Everything Sean Duffy said on any show that made the record, most notable first. Each card names its show and opens the statement there.
Duffy: Lifelong GLP-1 Prescriptions Contradict Patient Preferences Despite Clinical Recommendations
“Most patients tend to not want to be on these medicines for life, even though, you know, I mean, you will find the KOLs that are, you know, argue that that's the right clinical point of view right now. That's counter to the patient preference.”
Duffy: Weight Regained After Stopping GLP-1 Medications Consists Exclusively Of Fat
“Because what's happening with these meds, you'll, you'll lose fat. And muscle mass, if you do regain, you're going to regain only fat.”
Duffy: Primary Care Will Not Manage Longitudinal Diabetes In A Decade
“Like there is no way That a decade from now, the primary care clinician is going to be point on something like longitudinal diabetes care.”
Duffy: Older patients engage and perform better in digital health programs
“It turns out that age, the older you are, the better you actually do, which is a little bit counterintuitive. You know, I think that it would be easy to think, well, digital, of course, young people are going to do it. Young people are going to do better, but …”
Duffy: Current AI cannot handle relationship-forward elements of healthcare
“Yet when you look at the majority of the complexity in scaling and all the challenges in building a business, a lot of it's very, very People forward and relationship forward. And it's all those kind of softer, kind of tougher elements that right now the world…”
Digital health startups avoid the baggage of salaried primary care physicians
“The advantage that both of us have for our businesses is we're starting from kind of a clean slate where you don't have to deal with the baggage of already having 10,000, you know, 2000 primary care docs on salary and managing that immense workflow shift that …”
Duffy: AI Models Are Commodities; Proprietary Data Is The True Differentiator
“Cause I mean, you know, at the end of the day, like, you know, these models are more or less commodities. It's what feeds them. That's important.”
Duffy: Tactical Execution Matters More To Startup Outcomes Than High-Level Strategy
“It's never the strategic stuff that tends to matter as much as the tactical things.”
Omada Health Will Not Prescribe GLP-1s, Focusing Instead On Lifestyle Support
“Amada's made some decisions we're happy about, you know, the first is to launch this like GLP one care track. And then we, you know, we've chosen to not initiate people on the medicines, but just, you know, support them regardless of where the script came from…”
Duffy: Omada Health achieves $1,300 in annual medical savings per enrollee
“We have claims data now that look out a year and see 1300 in savings per enrollment.”
Duffy: Shared savings models strain client relationships over actuarial attribution disputes
“The slight challenge with that is you get in this reconciliation moment at the end of the year where it's like, You know, where's the attribution? You know, it's kind of my actuaries versus yours, and it's kind of not a good way to foster just deep partnership…”
Duffy: Omada's Medicaid trial yields health outcomes comparable to its core business
“We're right now doing a big clinical trial in the safety net Medicaid space. And, you know, thus far, you know, the outcomes are quite comparable to book a business, I mean, in large part due to this personalization.”
Duffy: Behavioral programs reduced diabetes risk better than drugs in trials
“In the original diabetes prevention program trial, they actually looked to see if these programs delivered in person would Be better than drugs that they hypothesized to work. And they were, you know, a program delivered far more efficacy in diabetes risk redu…”
Duffy: Omada Health has amassed 11.5 million weight readings
“You look at what we've done, we've amassed about 11 and a half million weight readings. It's the largest longitudinal data set of these sorts of programs in the world.”
Sean Duffy: Omada Health possesses the largest longitudinal digital health dataset globally
“We've enrolled the largest longitudinal data set of these sorts of programs in the world”
Sean Duffy: Healthcare cannot be disrupted from the outside without existing stakeholders
“There's no, like, disrupt from the outside shortcut. It's kind of disrupt from, by working with the existing stakeholders and empathizing with them and understand, you know, what drives them and their needs.”
Duffy: Reaching One Million Patients Has Not Made Epidemiological Impact Yet
“But then if you compare the million to the task at hand of actually impacting epidemiology and really, you know, doing what we need to do for the business we haven't really, really made a dent yet.”
Duffy: The Startup Label Was A Liability In Enterprise Healthcare Sales
“The key thing was that it was not sexy to be a startup. This was kind of a moment in time where, you know, it was like, oh my gosh, the zeitgeist was that 20 something founder that goes off and builds like a ten billion dollar company. And you'd be with these …”
Omada Health Secured The First Digital-Specific CPT Code From The AMA
“We figured out a way to build through claims. We took our. Trials to the American Medical Association, got them to issue the first ever digital specific CBT code, just literally for billing infrastructure.”
Duffy: Rising Tech Fluency In Life Sciences Simplifies Building Healthtech Startups
“Today's cursive is JavaScript. So you're not it's not, so there's just more. Tech fluidity coming out of the, you know, I think the life sciences. Which speaks to more talent that can appreciate both worlds, which speaks to cultures that can build the best of …”
Duffy: Founders Must Intentionally Decouple The Founder And CEO Mindsets
“I always encourage entrepreneurs to like, especially founders try to purposely decouple yourself From the founder mind and the CEO mind.”
Duffy: Early Pricing And Packaging Choices Create Massive Startup Path Dependency
“My number one advice is put a ton of thought in how you price and package kind of what you've, what you're buying. That has just so much path dependency.”
Duffy: AI Cannot Replace Human Accountability And Empathy In Healthcare
“There's a reason that artificial intelligence is a buzzword and artificial empathy is not. And I don't think there is any substitute substitute for just the human accountability.”
The other half of the tape: Sean Duffy's own voice is left out of every number here. Other people bring the name up 1 time in 1 episode across the shows. every mention, with the transcript →
Who brings them up most Philip Buckendorf 1
Every mention by year
tap a year for its mentions
the a16z Podcast 1
2025 1 mention in 1 episode
One line per show, most statements first. The link opens Sean's full record on that show: the calibration, argument clarity, speaking style and every statement made there.
| Show | Role there | Eps | Statements | Record | |
|---|---|---|---|---|---|
| a16zLEDGER | Co-Founder and CEO, Omada Health | 4 | 46 | 80% 12/15 | full record on the a16z Podcast → |